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1. Introduction 
Pituitary gland, also called hypophysis, is a neuroendocrine organ placed in the “sella 
turcica” in the skull base. This gland consists of 2 main areas, the anterior and medial part 
constitute the adenohypophysis, the posterior part is called neurohypophysis. Pituitary 
gland is in charge of the internal constancy, homeostasis and reproductive function; this is 
why pituitary abnormalities cause a wide spectrum of signs and symptoms.  
Pituitary adenomas are a common pathology; they represent about 10% of all intracranial 
tumours and between 50-80% of pituitary tumours. Necropsy and imaging studies estimate 
an incident of 20-25% of pituitary adenomas in general population; however, only about 1/3 
of them are clinically evident (Asa & Ezzat, 2009). The majority of these tumours have 
monoclonal origin (mutation of a single gonadotropic cell), but there are still some 
discrepancies about the pathogenesis of these neoplasms. The most common mutations 
seem in other human neoplasms are not frequent in pituitary adenomas, and only a 
minimum proportion of them are associated to other genetic disorders, such as MEN1 
syndrome (multiple endocrine neoplasms type 1)  or the Carney complex, due to mutations 
of the genes MEN1 and PRKAR1A (protein kinase A regulatory subunit 1A) respectively 
(Beckers & Daly, 2007). Hormones and growth factors involve in normal pituitary function 
can be also related to the growth of these tumours, although evident connection with the 
pathogenesis has not been demonstrated. 
Symptoms related to pituitary tumours are secondary to several factors. On the one hand, 
many of them are non-secreting tumours, they can be asymptomatic or cause compression 
symptoms if they are big enough; on the other hand, other are secreting tumours and they can 
cause clinical syndromes derivate from the hormone activity in different target organs. 
Hormones secreting by these tumours are the same that the physiologic hypophysis 
produces. According to frequency, the most frequent tumours are prolactin (PRL)-secreting 
pituitary adenomas, non secreting pituitary adenomas are in second position, growth 
hormone (GH)-secreting tumours in third, adrenocorticotropic hormone (ACTH)-secreting 
tumours in fourth, and the rarest are thyroid stimulating hormone (TSH)-secreting 
adenomas. There are also tumour secreting different combinations of hormones, mainly GH 
and PRL (Table 1). In cases of fast growing or big tumours affecting surrounding structures, 
chiasmatic or cavernous sinus syndrome can be seen.  
Two types of adenomas can be described depending on the size of the tumour, 
macroadenomas with more than 1 centimeter and microadenomas measuring less than 1 cm 
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in size (figure 1). A low percentage of tumours have a malign behaviour producing 
metastases, central nervous system invasion and even death; nevertheless, this is very 
uncommon and the majority of the problems related to these tumours are due to the 
morbidity that they produce. 
 
Cell type Hormones 
Hormone 
function 
Tumour 
incidence 
Clinical 
syndromes 
Adrenocorticotropic ACTH and 
other 
peptides
Adrenal cortex; 
glucocorticoid 
metabolism
10 – 15% 
Cushing 
syndrome 
Nelson syndrome 
Somatotropic 
GH 
IGF-1 
production. 
Muscle and bone 
growth 
10 – 15% 
Acromegaly 
Gigantism 
Lactotropic 
PRL 
Lactation
35% 
Amenorrhea 
Galactorrhea 
Sexual 
dysfunction 
Mammo-
somatotropic GH , PRL 
See above
5% 
Acromegaly 
Gigantism with 
hyper-PRL 
Thyrotropic 
TSH 
Thyroid 
metabolism
2% 
Hypo - 
hyperthyroidism 
Gonadotropic 
FSH, LH 
Sexual 
development. 
Sexual steroids 
metabolism 
35% 
Hypogonadism     
Mass effect 
Hypopituitarism 
Table 1. Pituitary cells, hormones, tumours and associated clinical syndromes (Asa & Ezzat, 
2002) 
 
Fig. 1. Magnetic resonance imaging showing a pituitary macroadenoma. 
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The wide spectrum of clinical syndromes including endocrinological, cardiovascular, 
neurological, ophthalmological, determine the needed of a multidisciplinary management 
between different specialists. Early diagnosis is very important in order to establish a proper 
therapeutic plan and achieve the best prognosis for these patients. 
In this review, a comprehensive description about the ophthalmological syndromes 
associated to pituitary adenomas is presented. The suspicion of these syndromes by the 
doctors facing patients with pituitary tumours will allow earlier diagnostic and better 
treatments for them. Despite the general ophthalmic examination including visual field 
tests, we describe the Optical Coherence Tomography (OCT) as a new tool that must be 
performed in all these patients.  
2. Ophthalmic manifestations of pituitary adenomas 
The most common neuro-ophthalmological syndrome associated to pituitary adenomas is 
due to compression of the central part of the optic chiasm; this produces the classic 
bitemporal hemianopia in the visual field. That was the onset manifestation in up to 80% of 
pituitary adenomas several years ago, but nowadays, the advantages in the hormone 
detection tests and neuroimaging have changed this trend, and headache and systemic 
clinical syndromes related to hormone production are the commonest onset manifestations. 
Neuro-ophthalmological manifestations are the debut syndrome in less than 10% of cases 
(Table 2); they are due to the anatomical relations between the gland and the optic chiasm, 
the optic nerves and the III, IV and VI nerves in the cavernous sinus.  
 
Study. No of 
patients 
Year 
Amenorrhea/ 
Impotence(%)
Headache 
(%) 
Visual 
dysfunction 
(%) 
Optic 
atrophy 
(%) 
EOM 
impairment 
Chamblin et al 
(156;<1955) 
-- -- 86 50 5 
Hollenhorst and 
younge 
(1000;1940-62) 
5 
 
14 70 34 6 
Klauber et al 
(51; 1967-74) 
 45 69 47  
Wray (100; 
1974-76) 
21 24 31 19 4 
Anderson et al 
(200; 1976-1981) 
70 46 9 2 1 
EOM: extraocular muscle 
Table 2. Debut signs and symptoms in pituitary adenoma patients (Chhabra & Newman, 
2006)  
2.1 Anatomy of the pituitary area (Rouvière & Delmas, 1996) 
Optic nerves enter the intracranial space through the optic foramen in the sphenoid bones, 
after 8-15 mm up and backwards they join together to constitute the optic chiasm. There are 
anatomical variations in the length of the intracranial optic nerve and the position of the 
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optic chiasm, this is extremely important with respect to the visual deficits caused by 
tumours in the suprasellar region. In 75-80% of people optic chiasm is placed just above the 
diaphragma sellae; when the intracranial optic nerve is shorter than about 12 mm (about 10% 
of people), the optic chiasm is positioned anteriorly, or “pre-fixed”, and it sits above the 
tuberculum sellae, when the intracranial optic nerve is long, over 18 mm (10-15% of people), 
the chiasm is positioned posteriorly to the dorsum sellae or “post-fixed” (Chhabra & 
Newman, 2006; Miller N, et al, 2008). 
Fibers running from the nasal retinal nerve cells (about 53% of fibers) cross in the chiasm to 
join the fibers from the temporal retinal nerve cells of the opposite side. However, as they 
enter the chiasm, some ventral crossed fibers, primarily from the inferonasal retinal of the 
contralateral eye and serving the superotemporal portion of the contralateral visual field, 
where historically believed to loop anteriorly 1 to 2 mm into the terminal portion of the 
opposite optic nerve before turning posteriorly to continue through the chiasm and into the 
optic tract. This loop is called Willebrand’s Knee (Miller N, et al, 2008; Muñoz-Negrete & 
Rebolleda, 2002). There is some controversy about the real anatomical existence of this 
structure, however Willebrand’s knee clearly exists from a clinical point of view, as it is 
described below. In cases of chiasm compression the crossed fibers are more likely to be 
damaged as they support the same quantity of pressure in less space (Kosmorsky, et al, 
2008). This is the reason for the bitemporal hemianopia (crossed nasal fibers compression) as 
the more frequent syndrome in cases of chiasm compression. Fibers leave the chiasm 
backwards in both sides of the hypophysis as the optic tracts; in cases of pre-fixed chiasms is 
more likely to see damaged of these tracts.  
The pituitary gland lies between the two paired cavernous sinuses. An abnormally growing 
adenoma will expand in the direction of least resistance and eventually compress the 
cavernous sinus (figure 2). The cavernous sinus receives blood via the ophthalmic vein 
through the superior orbital fissure and from superficial cortical veins, and is connected to 
the basilar plexus of veins posteriorly. The internal carotid artery (carotid siphon), and 
cranial nerves III, IV, V1, V2 and VI all pass through this blood filled space. The cavernous 
sinus drains by two channels, the superior and inferior petrosal sinuses, ultimately into the 
internal jugular vein. These nerves, with the exception of V2, pass through the cavernous 
sinus to enter the orbital apex through the superior orbital fissure. The maxillary nerve, 
division V2 of the trigeminal nerve travels through the lower portion of the sinus and exits 
via the foramen rotundum (Miller N, et al, 2008; Frank, et al, 2006). 
2.2 Clinical syndromes 
There are different syndromes that can be seen in cases of pituitary adenomas: 
2.2.1 Anterior chiasmal syndrome 
This is more common in post-fixed chiasms. The compression in the anterior angle of the 
optic chiasm affect the Willbrandt’s knee fibers and produces temporal and superior visual 
field defects affecting one or both eyes. In cases of non-centred tumours the anterior junction 
syndrome of Traquair (junctional scotoma) can be observed, characterized by advanced 
visual field loss affecting the visual field centre in one eye and (possibly subtle) defects 
respecting the vertical midline in the fellow eye (Muñoz-Negrete & Rebolleda, 2002). 
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Fig. 2. Anatomy of the cavernous sinus and surrounding structures. Relation between the 
pituitary gland and the chiasm, cranial nerves and internal carotid arteries. 
2.2.2 Central chiasmal syndrome  
This is the most frequent syndrome; the damage involving mainly the crossed fibers 
produces bitemporal hemianopia with possible central visual field affectation (figure 3). 
This syndrome is seen in lesions that damage the body of the optic chiasm. 
 
Fig. 3. Visual field showing a bitemporal hemianopia. 
2.2.3 Inferior chiasmal syndrome  
If the compression affects predominantly the inferior part of the chiasm the visual field 
defects are temporal and superior.  
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2.2.4 Superior chiasmal syndrome 
Compression of the superior part of the chiasm is not a frequent condition in cases of 
pituitary adenomas; it is more likely to see this clinical picture in other tumours arising from 
the base of the brain, mainly the craniopharyngioma. In these cases the visual field defects 
are temporal and inferior. 
2.2.5 Posterior chiasmal syndrome  
More frequent in pre-fixed chiasms. It produces characteristic bitemporal hemianopic 
scotomas in the visual field.  
2.2.6 Lateral chiasmal syndrome 
This syndrome can be observed in tumours compressions or carotid pathology that pushes 
the chiasm laterally. Contralateral homonymus quadrantanopic or hemianopic defects can 
be assessed; much less frequent is the binasal hemianopia in these cases.  
2.2.7 Optic tract compression  
This is also more frequent in cases of post-fixed chiasms. Contralateral homonymus defects 
can be observed. Optic tract damage is more frequent in other neurological conditions, such 
as vascular processes, demyelinating diseases or trauma. Another pupillary phenomenon 
that is sometimes associated with lesions of the optic tract that produce a complete or nearly 
complete homonymus hemianopia is pupillary hemiakinesia (hemianopic pupillary reaction 
or Wernicke’s pupil) (Miller N, et al, 2008).  
2.2.8 Neuro-ophthalmological signs and symptoms associated with the chiasmal 
syndrome 
The presence of visual field defect can associate different manifestations, such as the 
hemifield slide phenomenon that produces fluctuating diplopia with no oculomotor 
impairment due to anomalous retinal correspondence. It is also common a disturbance of 
depth perception. These two phenomenons are associated to bitemporal hemianopia (Chhabra 
& Newman, 2006; Miller N, et al, 2008). 
2.2.9 Ocular motility disorders  
Patients with pituitary pathology can refer diplopia related to the mentioned hemifield slide 
phenomenon, or due to cranial nerves damage in the cavernous sinus; the most frequently 
affected is the third nerve leading to an eyelid ptosis, pupillary dilation, and ocular motility 
disorders (figure 4). The rarest of those syndromes is the VI nerve palsy.  
2.2.10 Nystagmus  
In cases of tumours of the diencephalon and chiasmal regions the rare phenomenon of the 
“see-saw” nystagmus may occur. This condition is characterized by synchronous alternating 
elevation and incyclotorsion of one eye and depression and excyclotorsion of the opposite 
eye. The pathogenesis of this phenomenon is not well understood but it is thought to be 
related to perception impairment connected with hemianopia (Chhabra & Newman, 2006) 
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Fig. 4. Patient affected by a III nerve palsy. Observe the eyelid ptosis due to affectation of the 
levator muscle. These patients also have pupillary dilation and extraocular movements 
impairment 
or damage to the interstitial nucleus of Cajal or adjacent structures of the tumour (Miller, et 
al, 2008). In cases of big tumours compressing the brainstem is also possible, although 
exceptional, the presence of nystagmus. 
2.2.11 Colour vision impairment  
This can be observed as a sign of visual pathway damage in different conditions, including 
cases of pituitary adenomas.  
2.2.12 Photophobia  
Some authors suggest that persistent photophobia of unknown aetiology should arise the 
suspicion of pituitary pathology (Kawasaki & Purvin, 2002). 
2.2.13 Pituitary apoplexy  
Defined as a sudden neurologic impairment, usually due to a vascular process. It is 
characterized by a sudden onset of headache, visual symptoms, altered mental status, and 
hormonal dysfunction due to acute hemorrhage or infarction of a pituitary gland. An existing 
pituitary adenoma is usually present. The incidence of this phenomenon has been described 
up to 10% in some series (Wakai, 1981). The visual symptoms may include both visual acuity 
impairment and visual field impairment from involvement of the optic nerve or chiasm and 
ocular motility dysfunction from involvement of the cranial nerves traversing the cavernous 
sinus (more frequent III nerve). Other less common symptoms are related to possible 
brainstem damage, such as light-near dissociation or convergence retraction nystagmus.  
2.2.14 Funduscopy  
Most of the cases show normal optic discs in fundus examination. If altered, it can be a diffuse 
atrophy, or more typically the “band” or “bow-tie” atrophy that occupies a more or less 
horizontal band across the disc with relative sparing of the superior and inferior portions 
where the majority of spared temporal fibers enter (figure 5). Some cases can develop 
papilledema, this is more frequently associated with suprachiasmal tumours that can invade 
and compress the 3rd ventricle, ultimately obstructing the flow of cerebrospinal fluid.  
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Fig. 5. Schematic representation of retinal nerve fibers (A). Optic disc of a patient with a 
pituitary adenoma showing atrophy of the nasal and temporal areas (“band” atrophy) and 
relative spare of the superior and inferior areas of the disc (B). 
2.2.15 Other neuro-ophthalmological manifestations 
Apart from the syndromes derivated from the tumour itself, the treatments used in these 
patients can produce neuro-ophthalmological side-effects:  
 Toxic dopaminergic psychosis caused by Bromocriptine. Treatment with this drug can 
also produce a quick tumour regression leading to an empty sella syndrome due to a 
herniation of the chiasm.   
 The surgical treatment most frequently performed today for these patients is the 
endoscopic trans-sphenoidal surgery. This technique can be also responsible for some 
ophthalmological side effects, mainly for damaging the optic nerves or the chiasm; 
nevertheless, the increasingly improvement in the equipment and surgical techniques 
allows treatments with much less complications (Cappabianca, et al, 2002). 
 Post-radiotherapy optic neuropathy. This is a minor problem nowadays because 
radiotherapy is an unusual treatment for these tumours, and also because of the 
improvement in the techniques using fractioned radiotherapy and protecting important 
structures such as the optic discs (Van den Bergh, et al, 2007). 
3. Visual recovery prediction factors  
During the last years different specialists involve in the management of pituitary adenomas 
have tried to establish prognostic factors of visual recovery after the treatment of these 
patients. To date there are several well recognize prognostic factors, such as the age of 
patients (the older the worse prognostic), the duration of the symptoms before the surgery, 
the size of the tumour (better prognostic in microadenomas) and the presence of pituitary 
apoplexy, which is a bad prognostic factor. From the ophthalmology point of view, several 
factors such as visual acuities less than 20/100 or a pale optic disc have been reported to 
determine a worse prognostic (Chhabra & Newman, 2006). 
Although some cases show a severe visual impairment, it is not unusual to observe 
important early recoveries (1st week), intermediate recoveries (1-4 months) or even late 
recoveries in some patients (up to 36 months after surgery) (Kerrison, et al, 2000). This 
www.intechopen.com
 Pituitary Adenomas and Ophthalmology 
 
9 
indicates that there must be other factors that determine different degrees of axonal 
affectation in different patients. One of the main current research lines in this field is 
actually seeking the diagnostic tools that allow us to predict the degree of axonal loss, and 
so the possibility of visual function recovery after the treatment.  
During the last years, OCT has been used to establish and quantifying the axonal loss in 
several neurological disorders. OCT is a non-invasive tool that allows the retina to be 
directly approached as an appendix of the central nervous system. We can measure 
peripapillary retinal nerve fiber layer (RNFL) thickness, a parameter which has been  
found to be reproducible and useful for the diagnosis, prognosis and follow-up of optic 
nerve axonal damage in several neurological diseases, including pituitary adenomas (Moura, 
et al, 2007; Parisi, 2003; Sergott, et al, 2007; Kallenbach & Frederiksen, 2007; Toledo, et al, 
2008; Noval, et al, 2006; Vessani, et al, 2009). (figure 6). OCT can be useful predicting  
   
 
Fig. 6. Optical Coherence Tomography. Observe the retinal nerve fiber layer (RNFL) 
measurement in microns. A diagram is included to analyze the different sectors of the optic 
disc and peripapillar area. This example shows thinning of the RNFL affecting the right eye 
(OD) predominantly in the superior and temporal quadrants, the left eye (OS) shows normal 
results. The bottom of the image shows funduscopy of both eyes and demonstrates the optic 
disc atrophy of the right eye (A) while the left eye is normal (B). 
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the visual  function recovery in patients with pituitary adenomas by measuring the axonal 
damage in the retina during the evolution of the disease (Ortiz-Perez, et al, 2009; Jacob, et al, 
2008). 
4. Conclusions 
Pituitary adenomas are a frequent pathology with a wide spectrum of clinical features. 
These tumours should be managed between different specialists including general 
practitioners, endocrinologists, neurologists, neurosurgeons and ophthalmologists. Neuro-
ophthalmological manifestations of pituitary adenomas are frequent and varied. They 
represent sometimes the onset symptoms in these patients. Many of the syndromes 
described above have an important diagnostic value due to their localizing information. 
Physicians must be aware about these syndromes in order to refer patients for 
ophthalmological assessments and establish an early diagnosis.  
OCT is a new device used daily in ophthalmology clinics to study the retina and optic disc. 
This tool gives unique and new information about the axonal loss in patients with 
neurological disorders, including pituitary adenomas. OCT is easily performed, it has no 
side effects or contraindications, so it must be included in the routine examination of 
patients with hypophysis tumours.  
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